Acadia Healthcare (NASDAQ:ACHC) Stock Price Expected to Rise, Barclays Analyst Says

Acadia Healthcare (NASDAQ:ACHC) had its price target boosted by analysts at Barclays from $32.00 to $35.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target would indicate a potential upside of 1.47% from the company’s current price.

Other research analysts have also recently issued reports about the stock. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a report on Tuesday, October 6th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Guggenheim raised their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Raymond James Financial downgraded Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target on the stock. in a research note on Monday, September 28th. Finally, TD Cowen upped their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $30.92.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded up $2.24 on Thursday, reaching $34.49. The company’s stock had a trading volume of 2,749,026 shares, compared to its average volume of 2,825,225. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $39.38. The stock has a market capitalization of $3.21 billion, a P/E ratio of -2.75, a PEG ratio of 9.54 and a beta of 0.64. The stock’s 50-day moving average is $29.18 and its two-hundred day moving average is $25.91. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The company had revenue of $895.31 million during the quarter, compared to analysts’ expectations of $877.76 million. During the same period last year, the firm earned $0.72 EPS. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts forecast that Acadia Healthcare will post 1.55 EPS for the current year.

Institutional Trading of Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the stock. Penn Capital Management Company LLC acquired a new stake in shares of Acadia Healthcare during the third quarter valued at $15,434,000. Prescott Group Capital Management L.L.C. raised its stake in Acadia Healthcare by 40.0% in the 3rd quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company’s stock valued at $1,925,000 after purchasing an additional 20,000 shares during the last quarter. Pinnacle Wealth Planning Services Inc. raised its stake in Acadia Healthcare by 20.7% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after purchasing an additional 550 shares during the last quarter. Congress Asset Management Co. raised its stake in Acadia Healthcare by 20.8% in the 3rd quarter. Congress Asset Management Co. now owns 287,390 shares of the company’s stock valued at $7,903,000 after purchasing an additional 49,418 shares during the last quarter. Finally, WINTON GROUP Ltd lifted its holdings in Acadia Healthcare by 1.4% in the 2nd quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock valued at $7,543,000 after purchasing an additional 3,449 shares in the last quarter.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, above the $0.46 analyst consensus, while revenue of $895.3 million exceeded expectations of $877.8 million and grew 5.1% year over year. Zacks earnings report
• Positive Sentiment: The company raised its full-year 2026 financial guidance, a constructive signal about management’s expectations for performance. Same-facility revenue rose 5.2%, supported by a 1.1% increase in patient days and a 4.0% increase in revenue per patient day. Company results and guidance announcement
• Negative Sentiment: Despite beating estimates, quarterly EPS was below the $0.72 reported a year earlier, a sign that earnings remain under pressure compared with the prior-year period. Zacks earnings report

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.